These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24856162)

  • 1. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application.
    Fujimoto I; Takei Y
    Ther Deliv; 2014 Apr; 5(4):369-71. PubMed ID: 24856162
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
    Kortylewski M; Nechaev S
    Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
    [No Abstract]   [Full Text] [Related]  

  • 3. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.
    Minakuchi Y; Takeshita F; Kosaka N; Sasaki H; Yamamoto Y; Kouno M; Honma K; Nagahara S; Hanai K; Sano A; Kato T; Terada M; Ochiya T
    Nucleic Acids Res; 2004 Jul; 32(13):e109. PubMed ID: 15272050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.
    Takeshita F; Minakuchi Y; Nagahara S; Honma K; Sasaki H; Hirai K; Teratani T; Namatame N; Yamamoto Y; Hanai K; Kato T; Sano A; Ochiya T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12177-82. PubMed ID: 16091473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine-lysine peptides as carriers of nucleic acids.
    Leng Q; Goldgeier L; Zhu J; Cambell P; Ambulos N; Mixson AJ
    Drug News Perspect; 2007 Mar; 20(2):77-86. PubMed ID: 17440630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better blocker: RNA interference dazzles research community.
    Garber K
    J Natl Cancer Inst; 2003 Apr; 95(7):500-2. PubMed ID: 12671010
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular medicine for the brain: silencing of disease genes with RNA interference.
    Davidson BL; Paulson HL
    Lancet Neurol; 2004 Mar; 3(3):145-9. PubMed ID: 14980529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference for the treatment of cancer.
    Putral LN; Gu W; McMillan NA
    Drug News Perspect; 2006; 19(6):317-24. PubMed ID: 16971967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-specific siRNA delivery by peptides and antibodies.
    Lee SK; Siefert A; Beloor J; Fahmy TM; Kumar P
    Methods Enzymol; 2012; 502():91-122. PubMed ID: 22208983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
    Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
    Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atelocollagen-mediated small interfering RNA delivery for effective gene silencing in rat vein grafts].
    Qiu XF; Dong NG; Sun ZQ; Su W; Shi JW
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):1028-31. PubMed ID: 19957819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of plasmid-lipid complexes for direct intratumoral injection.
    Kotipatruni RP; Nagaraju GP
    Methods Mol Biol; 2014; 1139():467-76. PubMed ID: 24619700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiber molecular model of atelocollagen-small interfering RNA (siRNA) complex.
    Svintradze DV; Mrevlishvili GM
    Int J Biol Macromol; 2005 Dec; 37(5):283-6. PubMed ID: 16405995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.